We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Smart Nanoparticles Designed to Identify, Target, and Kill Cancer Cells

By LabMedica International staff writers
Posted on 07 Apr 2010
Nanoparticles have been designed that can identify, target, and destroy specific cancer cells while leaving healthy cells alone.

Led by Dr. More...
Carl Batt, a professor of food science at Cornell University (Ithaca, NY, USA), the researchers synthesized nanoparticles--shaped similar to a dumbbell --made of gold sandwiched between two pieces of iron oxide. They then attached antibodies, which target a molecule found only in colorectal cancer cells, to the particles. Once bound, the nanoparticles are engulfed by the cancer cells.

To kill the cells, the researchers used a near-infrared laser, which is a wavelength that does not harm normal tissue at the levels utilized, but the radiation is absorbed by the gold in the nanoparticles. This causes the cancer cells to heat up and die. "This is a so-called ‘smart' therapy,” Dr. Batt said. "To be a smart therapy, it should be targeted, and it should have some ability to be activated only when it's there and then kills just the cancer cells.”

The goal, according to lead author and biomedical graduate student Dickson Kirui, is to improve the technology and make it suitable for testing in a human clinical trial. The researchers are now working on a similar experiment targeting prostate cancer cells. "If, down the line, you could clinically just target the cancer cells, you could then spare the health surrounding cells from being harmed--that is the critical thing,” Mr. Kirui said.

Gold has potential as a material key to combating cancer in future smart therapies. It is biocompatible, inert, and comparatively easy to modify chemically. By changing the size and shape of the gold particle, the investigators can tune them to respond to different wavelengths of energy.

Once taken up by the researchers' gold particles, the cancer cells are destroyed by heat--just a few degrees above normal body temperature--while the surrounding tissue is left unharmed. Such a low-power laser does not have any effect on surrounding cells because that specific wavelength does not heat up cells if they are not loaded up with nanoparticles, the researchers explained.

Using iron oxide, which is essentially rust, as the other parts of the particles might one day allow scientists to also track the progress of cancer treatments using magnetic resonance imaging, Mr. Kirui noted, by taking advantage of the particles' magnetic properties.

The research was published in the February 15, 2010, online edition of the journal Nanotechnology.

Related Links:

Cornell University




New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Gold Member
Automated Cell Culture Chemistry Analyzer
BioProfile FLEX2 Basic
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.